Substance abuse treatment encompasses a wide array of medicines and approaches for patients with a habit of abusing psychoactive substances. It can cause impairment or distress to the individual. The global substance abuse treatment market report by Market Research Future (MRFR) contains drivers, challenges, opportunities, and trends for the forecast period. The impact of the COVID-19 pandemic and its effects have been included as a catalyst.

Market Scope

The global substance abuse treatment market size is projected to expand at 11.6% CAGR over the forecast period. The prevalence of smoking among teenagers can drive the market demand exponentially. According to the study in the Clinical and Translational Investigation Journal, more than 60% of individuals start smoking by the age of 13. Technological advances in diagnostics, rising cases of drug addiction, and awareness of treatment options can bode well for the global substance abuse treatment market.

But poor adherence to treatment and hesitation among individuals for treatment can hamper market growth.

Segmentation

The global substance abuse treatment market is segmented based on abuse type, treatment type, and end user.

The global market for substance abuse treatment, by abuse type is segmented into drug abuse, alcohol dependence, and tobacco/nicotine addiction. The drug abuse segment is anticipated to hold the largest market share owing to the increasing addiction of opioid. According to the National Institute of Drug Abuse, nearly 90 million Americans have died due to opioid abuse.

The market insight, by treatment type, is segmented into alcohol addiction treatment, tobacco/nicotine addiction treatment, and drug abuse treatment. The alcohol addiction treatment segment is further classified into naltrexone, disulfiram, and acamprosate. The tobacco/nicotine addiction treatment segment is further classified into nicotine replacement treatment and non-nicotine medication. The nicotine replacement treatment segment includes nicotine spray, nicotine patch, nicotine lozenge, nicotine gum, and nicotine inhaler. The non-nicotine medication segment includes bupropion, and varenicline. The drug abuse treatment segment is further classified as methadone, buprenorphine, and naltrexone.

Based on end user, the market is segmented into inpatient treatment centers, outpatient treatment centers, and residential treatment centers.

Competitive Intelligence

The global substance abuse treatment market players are INSYS Therapeutics, Amphastar Pharmaceuticals, Opiant Technologies, Teva Pharmaceuticals, Mylan Laboratories, Glenmark, Sterinova, Allergan, Sun Pharmaceuticals, Sanquin, Lupin, Apotex, BioCorRx, Cipla, Forest Laboratories, Inc., Alkermes Plc, LFB Group, Accord Healthcare, Purdue Pharma LP, Pfizer Inc., Reckitt Benckiser Pharmaceuticals, Sanofi Aventis, and GlaxoSmithKline Plc.

Regional Analysis

The Americas dominated the global market for substance abuse treatment owing to presence of major market players and rising awareness about substance abuse treatment. In recent years, the launch of campaigns and seminar to spread awareness about substance abuse and commercials endorsed for treatment by celebrities can bode well for the regional market. For instance, in February 2017, the Ad Council and Viacom have launched the LISTEN campaign and a new PSA to address America’s substance abuse crisis.

In 2017, it was estimated that Europe stood second in the global substance abuse treatment market. This can be attributed to the rising research and development investments.

APAC was projected to be the fastest growing region in 2017. Factors such as increasing incidence of tobacco addiction, drug addiction, and increasing technological advancements within the region are boosting the market. According to the information published in the Frontiers in Psychiatry journal, China is facing an immense public health challenge from smoking. The number of deaths caused by cigarette smoking will reach 2 million by 2030 and 3 million by 2050.

On the other hand, the Middle East and Africa held least share in the global substance abuse treatment market due to the low per capita income especially within the African region.

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), & Consulting Services. MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street, 5Th Floor,

New York, New York 10013

United States of America

+1 628 258 0071

Email: sales@marketresearchfuture.com